Conclusion: Switching of the TNF antagonist over time is a common issue.
2
However, recent analyses of antagonist-occupied receptor function suggest a more complex picture.
3
General Saterges had found in Stephen Cordier a powerful antagonist in action.
4
Similar effects were observed when microglia were treated with LRP1 antagonist RAP.
5
Orexin antagonist leads to significant reduction of sympathetic over-activity during withdrawal syndrome.
1
The selective δ-opioid receptorantagonist naltrindole only partially blocked the effect of MMP-2200.
2
This effect was blocked only by the kappa-opioid receptorantagonist nor-BNI.
3
These effects of HC were significantly reversed by the glucocorticoid receptorantagonist RU486.
4
Another group received the thrombin receptorantagonist in combination with the standard anti-platelet treatments.
5
These changes were completely prevented by the AII receptorantagonist.
Uso de receptor antagonism em inglês
1
These doses were associated with well-defined pharmacological effects compatible with N-methyl-D-aspartate receptorantagonism.
2
Endothelin- receptorantagonism with oral bosentan is an effective approach to therapy for pulmonary arterial hypertension.
3
These results emphasize that ET receptorantagonism may yield different results in healthy and diseased states.
4
Insulin receptorantagonism increased pancreatic β-cell mass threefold.
5
Endothelin (ET) receptorantagonism is a potential therapeutic intervention in the treatment of vascular diseases.
6
The purpose of this study was to determine whether glycine receptorantagonism also reduces volatile anesthetic requirements in the rat.
7
In vitro testing of single receptors with binary odorant mixtures indicates that behavioral blocking can occur without receptorantagonism in the nose.
8
When analyzing motor activity in rats, acutely administered caffeine shows a profile of a non-selective adenosine receptor antagonist, although with preferential A1 receptorantagonism.
9
Diesel exhaust inhalation increases vascular sensitivity to ET-1 and reduces vasodilatation to ET(A) receptorantagonism despite unchanged plasma ET-1 concentrations.